IRIDEX Corporation (IRIX)
$0.85-8.60%Close
BUYRECOVERY · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $15M
- Beta
- 0.67
- P/E (TTM)
- -4.17
- Short % float
- 1.10%
- Days to cover
- 3.5
- SI change
- -17.9%
- 1W
- +25.00%
- 1M
- +32.81%
- vs SPY 1W
- +25.14%
- vs SPY 1M
- +30.31%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 4
- GROWTH
- 28
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-47.4%
REV YoY-
ROE-78.9%
EPS YoY-
ROA-13.0%
GROSS36
OP-5
NET-7
[VALUATION]
P/E TTM-4.17
P/E FWD-
SECTOR PE20.34
INDUSTRY PE22.66
P/B4.05
P/FCF-
EV/EBITDA-8.22
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E110.28
ALTMAN Z-
CURR RATIO1.82
ND/EBITDA-
BETA0.67
Company news
FAQ
- What is LOPJLB’s current signal on IRIX?
- LOPJLB’s latest quantitative signal on IRIDEX Corporation (IRIX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is IRIX in?
- IRIDEX Corporation (IRIX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does IRIDEX Corporation (IRIX) do?
- IRIDEX Corporation is a medical technology firm specializing in ophthalmology. They develop and supply advanced therapeutic laser systems, various delivery instruments, and essential consumable tools designed to address vision-threatening ocular conditions. Their product portfolio includes several laser consoles, each tailored for specific eye conditions. The Cyclo G6 system is specifically eng…